Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Both THC and CBD contribute to the sedative effects, helping individuals fall asleep faster and enjoy a more restful sleep.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Terpenes interact with both cannabidiol and THC and change the effects that either drug has on the body. Preliminary Research on CBD Oil. CBD is the most abundant active ingredient within the CBD oil.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Terpenes interact with both cannabidiol and THC and change the effects that either drug has on the body. Preliminary Research on CBD Oil. CBD is the most abundant active ingredient within the CBD oil.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

PrestoDoctor

SEPTEMBER 15, 2023

While there are a variety of treatments available, many individuals do not find relief with traditional medications or therapies. However, recent research suggests that cannabis may be a promising option for those seeking relief from OCD symptoms. It is a serious medical condition that requires appropriate treatment and support.

Research and Development 105

Research and Development Therapy Treatment Strains 105

Cannabis Law Report

NOVEMBER 29, 2019

Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. THC is the psychoactive compound in cannabis. But, THC has a similar chemical makeup with cannabidiol or CBD. CBD combats THC’s effects. THC alters communication functions. That’s why some people choose THC oil. THC Oil Benefits.

Oil 104

Oil THC Cannabinoids Research and Development 104

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research. Clinical Trial Sample Size.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. THC is the psychoactive compound responsible for the “high” associated with marijuana use.

Law 52

Law Dispensary Clinical Trials Programs 52

Weedistry

MARCH 7, 2019

Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find. She had been screening brain cancer cells because they grow faster than normal cell lines and thus are useful for research purposes. Instead of gaining insight into how cells function, Sanchez had stumbled upon the anti-cancer properties of THC.

THC 40

THC CBD Clinical Trials Research and Development 40

CannaMD

MAY 25, 2021

In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. THC, CBD & THE ECS. CBD PROMOTES BONE GROWTH. In their summary, the study’s authors noted that.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

The Cannigma

FEBRUARY 2, 2021

However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance.

Digestion 123

Digestion Treatment Conditions Research and Development 123

PrestoDoctor

OCTOBER 11, 2023

One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Some individuals may have delayed speech development or struggle with expressing their thoughts and emotions effectively. For years, the use of cannabis has been a controversial topic.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Cannabis Law Report

DECEMBER 21, 2021

CBG or cannabigerol is obtained from immature cannabis plants since it is not present in fully developed plants. In most fully developed cannabis plants with considerable THC and CBD concentrations, CBG levels are relatively low. It occurs because most of the CBG has been converted to CBD and THC as the plant has matured.

Conditions 52

Conditions Research and Development Clinical Trials Oil 52

CannaMD

JUNE 2, 2021

Non-uses were also asked what factors might cause them to consider adding medical marijuana to their treatment regime. A quarter of all users did not know the strain or THC/CBD content of the product they were using.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JANUARY 19, 2022

During his 24 years in Congress, Congressman Moran was recognized as a champion of innovative research and development in areas including healthcare and national security, environmental protection and sustainability, and international trade and fiscal responsibility. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

The Cannigma

JUNE 23, 2022

CBGA is naturally produced by the cannabis plant, and is the precursor to all of the phyto-, or plant-related cannabinoids like THC, CBD, CBN and CBG. Often CBGA is presumed to interact with CB1 and CB2 receptors, more similar to THC and or CBG, but emerging science suggests this is likely not the case. What does CBGA do?

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

The Joint Blog

JANUARY 12, 2020

However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” said Cornell University veterinary researcher Joseph Wakshlag: He studies therapeutic uses for the compound.

Pets 36

Pets CBD Clinical Trials Research and Development 36

Greencamp

FEBRUARY 17, 2019

The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. Crohn’s Disease and Marijuana: Efficacy, Research and Dosing. In fact, the risk of developing IBS increases after a gastrointestinal infection for about 10%. Research on cannabis and IBS.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

The first-ever cannabis-based drug with FDA approval is Epidiolex*, a new prescription drug designed to treat severe seizure disorders that do not respond to other treatments. GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Medical Marijuana In Pill Form, With FDA Approval.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

MedicalJane

JUNE 29, 2018

On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. branch of Aphria, Inc.,

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

MMJ Recs

JULY 11, 2020

An alarmingly high number of deaths in many countries has led to researchers scrambling to find an effective treatment or cure for the disease. One recent study conducted in Canada looked at whether marijuana might be an option for coronavirus treatment. The coronavirus pandemic has hit populations hard all over the world.

Research and Development 52

Research and Development Treatment Clinical Trials Therapy 52

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The research we completed is exploratory but the results are consistent with our earlier research. “The We look forward to the next chapters in their development”.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! But CBD’s stolen the spotlight, partially because of its good cop/bad cop relationship with another famous cannabinoid: T etrahydrocannabinol or THC. THC is responsible for marijuana’s psychoactive effects. What makes CBD special?

CBD 99

CBD DEA Research and Development Hemp 99

The Joint Blog

JANUARY 31, 2021

For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. Further research is needed to elucidate the clinical role and underlying biological mechanisms of action of cannabidiol-based extract in patients with autism spectrum disorder.”.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

The Joint Blog

NOVEMBER 26, 2019

For the study, researchers at Washington State University analyzed data from 1,959 anonymous marijuana consumers who tracked their marijuana use and headache frequency over a 16-month period. The study, titled Short and Long-term effects of cannabis on headaches and migraine , can be found by clicking here.

Clinical Trials 55

Clinical Trials Research and Development Marijuana Data 55

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Severe treatment-resistant epilepsy. Consider nabilone as an add-on treatment for adults (18 years and over) with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics. THC ( delta-9-tetrahydrocannabinol). THC ( delta-9-tetrahydrocannabinol).

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

The Joint Blog

MARCH 18, 2021

According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS). Researchers examined studies that used both natural and synthetic THC and CBD.

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

Cannabis Law Report

DECEMBER 28, 2021

THC, or tetrahydrocannabinol, in cannabis plants has psychoactive properties, mainly responsible for causing high as it binds to the high causing receptors of the brain. Moreover, the FDA has also allowed researchers to conduct CBD trials. But things have changed after FDA eased out regulations in 2015 to carry out CBD trials.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52